Immuneel’s CAR-T cell therapy reports positive in early phase-2 trials in India
Immuneel, the cell and gene remedy startup, which is growing chimeric antigen receptor T (CAR-T) cell remedy Varnimcabtagene, on Tuesday ...
Immuneel, the cell and gene remedy startup, which is growing chimeric antigen receptor T (CAR-T) cell remedy Varnimcabtagene, on Tuesday ...
Copyright © 2022 Asia Today.